Skip to Main content Skip to Navigation
Journal articles

Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan

Abstract : BACKGROUND: FOLFIRINOX (leucovorin, 5-fluorouracil, irinotecan, and oxaliplatin) is an option for fit patients with metastatic (MPC) and locally advanced unresectable (LAPC) pancreatic cancer. However, no criteria reliably identify patients with better outcomes. PATIENTS AND METHODS: We investigated putative prognostic factors among 137 MPC/LAPC patients treated with triplet chemotherapy. Association with 6-month survival status (primary endpoint) was assessed by multivariate logistic regression models. A nomogram predicting the risk of death at 6 months was built by assigning a numeric score to each identified variable, weighted on its level of association with survival. External validation was performed in an independent data set of 206 patients. The study was registered at ClinicalTrials.gov (NCT03590275). RESULTS: Four variables (performance status, liver metastases, baseline carbohydrate antigen 19-9 level, and neutrophil-to-lymphocyte ratio) were found to be associated with 6-month survival by multivariate analysis or had sufficient clinical plausibility to be included in the nomogram. Accuracy was confirmed in the validation cohort (C index = 0.762; 95% confidence interval, 0.713-0.825). After grouping all cases, 4 subsets with different outcomes were identified by 0, 1, 2, or > 2 poor prognostic features (P < .0001). CONCLUSION: The nomogram we constructed accurately predicts the risk of death in the first 6 months after initiation of FOLFIRINOX in MPC/LAPC patients. This tool could be useful to guide communication about prognosis, and to inform the design and interpretation of clinical trials.
Complete list of metadatas

Cited literature [38 references]  Display  Hide  Download

https://hal-univ-rennes1.archives-ouvertes.fr/hal-02307162
Contributor : Laurent Jonchère <>
Submitted on : Monday, May 18, 2020 - 2:53:26 PM
Last modification on : Tuesday, October 27, 2020 - 2:34:44 PM

File

Fornaro et al-2019-Validated n...
Files produced by the author(s)

Identifiers

Citation

Lorenzo Fornaro, Francesco Leone, Angélique Vienot, Andrea Casadei-Gardini, Caterina Vivaldi, et al.. Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan. Clinical Colorectal Cancer, Elsevier, 2019, 18 (4), pp.e394-e401. ⟨10.1016/j.clcc.2019.08.004⟩. ⟨hal-02307162⟩

Share

Metrics

Record views

105

Files downloads

249